VIA
DXCM icon

Vident Investment Advisory’s DexCom DXCM Stock Holding History

Vident Investment Advisory’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,554
Closed -$457K – 306
2023
Q2 		$457K Buy
3,554
+544
+18% +$65.8K 0.02% 725
2023
Q1 		$350K Buy
3,010
+304
+11% +$34K 0.01% 899
2022
Q4 		$306K Buy
+2,706
New +$297K 0.01% 882
2022
Q3 		– Sell
-2,831
Closed -$213K – 1158
2022
Q2 		$213K Buy
2,831
+15
+0.5% +$1.37K 0.01% 1112
2022
Q1 		$366K Sell
2,816
-4,732
-63% -$518K 0.01% 1023
2021
Q4 		$1.01M Sell
7,548
-6,716
-47% -$965K 0.03% 703
2021
Q3 		$1.95M Buy
14,264
+824
+6% +$104K 0.06% 427
2021
Q2 		$1.44M Sell
13,440
-8,152
-38% -$783K 0.04% 541
2021
Q1 		$1.94M Sell
21,592
-376
-2% -$35.3K 0.07% 392
2020
Q4 		$2.03M Buy
21,968
+300
+1% +$26.8K 0.08% 274
2020
Q3 		$2.23M Sell
21,668
-3,584
-14% -$374K 0.11% 178
2020
Q2 		$2.56M Sell
25,252
-2,972
-11% -$266K 0.13% 145
2020
Q1 		$1.9M Sell
28,224
-192
-0.7% -$11.9K 0.12% 184
2019
Q4 		$1.55M Sell
28,416
-680
-2% -$32.3K 0.1% 326
2019
Q3 		$1.09M Buy
29,096
+56
+0.2% +$2.18K 0.09% 168
2019
Q2 		$1.09M Sell
29,040
-148
-0.5% -$4.65K 0.09% 163
2019
Q1 		$869K Buy
29,188
+568
+2% +$20K 0.05% 443
2018
Q4 		$857K Sell
28,620
-804
-3% -$25.5K 0.05% 449
2018
Q3 		$1.05M Sell
29,424
-2,820
-9% -$87.4K 0.04% 459
2018
Q2 		$765K Buy
+32,244
New +$684K 0.03% 502

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vident Investment Advisory's DXCM Position: Q3 2023 in Review

Vident Investment Advisory sold out of DexCom (DXCM) in Q3 2023, closing a stake of 3,554 shares — an estimated $457K sold.

Vident Investment Advisory first reported a position in DXCM in Q2 2018 and held it in 20 quarters. The position peaked at $2.56M in Q2 2020. 902 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Vident Investment Advisory reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 3,554 DexCom shares in Q3 2023, an estimated $457K.
  • Vident Investment Advisory first reported a position in DexCom in Q2 2018 and held it in 20 quarters.
  • Vident Investment Advisory's DexCom position peaked at $2.56M in Q2 2020.
  • 902 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.